BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use

MENLO PARK, Calif., Jan. 23, 2023 /PRNewswire/ -- BillionToOne, Inc., a next-generation molecular diagnostics company, is excited to announce the appointment of Dr. Gary Palmer as Chief Medical Officer (CMO), Oncology, and the launch of its Northstar liquid biopsy assays for commercial...

Click to view original post